|
Market Closed -
Nasdaq
06:00:00 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 36.60 USD | +1.30% |
|
+7.43% | +7.62% |
| 01/09 | UBS Initiates Assembly Biosciences at Buy With $52 Price Target | MT |
| 21/08 | Certain Common Stock of Assembly Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 21-AUG-2026. | CI |
| Market Cap | 745M 641M 603M 551M 1.03B 70.36B 1.03B 7.13B 2.77B 36.1B 2.8B 2.74B 116B | P/E 2026 * |
-314x | P/E 2027 * | -13.3x |
|---|---|---|---|---|---|
| Enterprise Value | 659M 567M 533M 487M 911M 62.19B 914M 6.3B 2.45B 31.91B 2.47B 2.42B 103B | EV / Sales 2026 * |
10.4x | EV / Sales 2027 * | 18x |
| Free-Float |
72.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ASMB | Delayed | |
CBOE
| ASMB | Real-time | |
|
Boerse Muenchen
| V7B | Real-time | |
|
Deutsche Boerse AG
| V7B | Delayed | |
|
Börse Stuttgart
| V7B | Delayed | |
|
Tradegate
| V7B | Real-time |
Last Transcript : Assembly Biosciences, Inc.
| 1 day | +1.30% | ||
| 1 week | +7.43% | ||
| Current month | +8.83% | ||
| 1 month | +38.43% | ||
| 3 months | +51.80% | ||
| 6 months | +22.86% | ||
| Current year | +7.62% |
| 1 week | 32.92 |  | 37.01 |
| 1 month | 26.18 | | 37.01 |
| Current year | 21.8 | | 37.01 |
| 1 year | 20.23 | | 39.7 |
| 3 years | 7.69 | | 39.7 |
| 5 years | 7.69 | | 42.6 |
| 10 years | 7.69 | | 808.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 50 | 01/01/2023 |
| Director of Finance/CFO | - | 05/06/2025 | |
Katie Kitrinos
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Altig
CHM | Chairman | 70 | 04/06/2026 |
Susan Mahony
BRD | Director/Board Member | 61 | 14/12/2017 |
John McHutchison
BRD | Director/Board Member | 68 | 06/08/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/6/26 | Free | Director | 8,000 | 0.0514% | ||
| 4/6/26 | Free | Director | 8,000 | 0.0514% | ||
| 4/6/26 | Free | Director | 8,000 | 0.0514% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | +7.43% | +57.01% | +211.22% | 745M | |
| -2.54% | -2.84% | -1.90% | +14.52% | 48.93B | |
| -0.40% | +1.03% | +439.20% | +499.20% | 45.01B | |
| -1.42% | +2.30% | +45.46% | +19.36% | 44.07B | |
| -1.22% | -2.31% | +12.40% | +71.48% | 40.73B | |
| +0.53% | -1.36% | +16.04% | +48.23% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +22.59% | +116.19% | 16.5B | |
| -1.01% | +0.50% | +15.83% | +27.98% | 14.67B | |
| -1.65% | -1.03% | +77.75% | +37.63% | 13.77B | |
| Average | -0.70% | +0.86% | +76.04% | +116.20% | 27.57B | |
| Weighted average by Cap. | -1.03% | +0.12% | +94.75% | +122.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.43M 54.58M 51.35M 46.91M 87.76M 5.99B 88M 607M 235M 3.07B 238M 233M 9.9B | 34.4M 29.6M 27.85M 25.44M 47.59M 3.25B 47.72M 329M 128M 1.67B 129M 126M 5.37B |
| Net income | 1.4M 1.21M 1.14M 1.04M 1.94M 132M 1.95M 13.43M 5.21M 67.98M 5.27M 5.15M 219M | -57.21M -49.23M -46.32M -42.31M -79.15M -5.4B -79.37M -547M -212M -2.77B -215M -210M -8.93B |
| Net Debt | -86.48M -74.42M -70.02M -63.96M -120M -8.17B -120M -827M -321M -4.19B -325M -318M -13.5B | -127M -109M -103M -93.84M -176M -11.98B -176M -1.21B -471M -6.15B -476M -466M -19.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | USD 36.60 | +1.30% | 156,451 |
| 03/09/26 | USD 36.13 | -1.61% | 224,976 |
| 02/09/26 | USD 36.72 | +4.38% | 267,541 |
| 01/09/26 | USD 35.18 | +4.61% | 301,100 |
| 31/08/26 | USD 33.63 | -1.29% | 235,972 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ASMB Stock
Select your edition
All financial news and data tailored to specific country editions
